Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Feb-23 7:00 PM View:  | Farmer Glen A Chief Financial Officer | Immune Therapeutics, Inc. (IMUN) | 10-Feb-23 | Private Purchase | 409,000 | $0.05 | $18,405.00 | 100% 0 to 409.0K | |
| 04-Jun-21 8:49 PM View: | Griffin Noreen 10% Owner | Immune Therapeutics, Inc. (IMUN) | 28-May-21 | Acquisition (other) | -- | -- | -- | 0% 3.82K | |
| 04-Jun-21 8:49 PM View: | Griffin Noreen 10% Owner | Immune Therapeutics, Inc. (IMUN) | 28-May-21 | Acquisition (other) | -- | -- | -- | 0% 3.82K | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 28-Dec-17 | Purchase | 30,000 | $0.02 | $600.00 | < 1% 12.92M to 12.95M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 27-Dec-17 | Purchase | 40,000 | $0.02 | $863.00 | < 1% 12.91M to 12.95M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 19-Dec-17 | Purchase | 70,000 | $0.01 | $700.00 | < 1% 21.99M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 15-Dec-17 | Purchase | 5,000 | $0.01 | $50.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 13-Dec-17 | Purchase | 65,000 | $0.01 | $807.00 | < 1% 12.88M to 12.95M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 13-Dec-17 | Purchase | 5,000 | $0.01 | $50.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 11-Dec-17 | Purchase | 30,000 | $0.01 | $433.50 | < 1% 12.92M to 12.95M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 08-Dec-17 | Purchase | 45,000 | $0.02 | $689.62 | < 1% 12.9M to 12.95M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 07-Dec-17 | Purchase | 25,000 | $0.02 | $391.50 | < 1% 12.92M to 12.95M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 06-Dec-17 | Purchase | 20,000 | $0.01 | $278.00 | < 1% 12.93M to 12.95M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 06-Dec-17 | Purchase | 23,000 | $0.02 | $460.00 | < 1% 22.04M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 05-Dec-17 | Purchase | 174,000 | $0.02 | $2,880.00 | < 1% 21.89M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 04-Dec-17 | Purchase | 35,000 | $0.02 | $622.00 | < 1% 12.91M to 12.95M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 01-Dec-17 | Purchase | 30,000 | $0.02 | $686.50 | < 1% 38.82M to 38.85M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 01-Dec-17 | Private Purchase | 10,000 | $0.02 | $198.00 | < 1% 12.94M to 12.95M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 01-Dec-17 | Purchase | 170,000 | $0.02 | $3,400.00 | < 1% 21.89M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 30-Nov-17 | Purchase | 20,000 | $0.02 | $400.00 | < 1% 22.04M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 29-Nov-17 | Purchase | 10,000 | $0.01 | $140.00 | < 1% 38.84M to 38.85M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 29-Nov-17 | Purchase | 20,000 | $0.01 | $200.00 | < 1% 22.04M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 28-Nov-17 | Purchase | 10,000 | $0.01 | $100.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 27-Nov-17 | Purchase | 12,000 | $0.02 | $190.80 | < 1% 38.84M to 38.85M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 24-Nov-17 | Purchase | 5,000 | $0.02 | $100.00 | < 1% 22.05M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 22-Nov-17 | Private Purchase | 27,000 | $0.02 | $540.00 | < 1% 22.03M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 21-Nov-17 | Purchase | 20,000 | $0.02 | $358.00 | < 1% 38.83M to 38.85M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 21-Nov-17 | Purchase | 50,000 | $0.02 | $1,000.00 | < 1% 22.01M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 20-Nov-17 | Purchase | 10,000 | $0.02 | $180.00 | < 1% 38.84M to 38.85M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 17-Nov-17 | Purchase | 10,000 | $0.02 | $190.00 | < 1% 38.84M to 38.85M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 14-Nov-17 | Purchase | 28,000 | $0.02 | $560.00 | < 1% 22.03M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 10-Nov-17 | Purchase | 10,000 | $0.02 | $200.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 10-Nov-17 | Purchase | 10,000 | $0.02 | $227.00 | < 1% 38.84M to 38.85M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 08-Nov-17 | Purchase | 10,000 | $0.02 | $230.00 | < 1% 38.84M to 38.85M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 07-Nov-17 | Purchase | 10,000 | $0.02 | $230.00 | < 1% 38.84M to 38.85M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 04-Nov-17 | Purchase | 4,000 | $0.03 | $112.00 | < 1% 38.84M to 38.85M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 02-Nov-17 | Purchase | 10,000 | $0.02 | $200.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 02-Nov-17 | Purchase | 10,000 | $0.02 | $240.00 | < 1% 38.83M to 38.84M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 31-Oct-17 | Purchase | 5,000 | $0.03 | $150.00 | < 1% 22.05M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 30-Oct-17 | Purchase | 5,000 | $0.03 | $150.00 | < 1% 22.05M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 25-Oct-17 | Purchase | 100,000 | $0.02 | $2,000.00 | < 1% 21.96M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 24-Oct-17 | Purchase | 10,000 | $0.02 | $200.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 20-Oct-17 | Purchase | 10,000 | $0.02 | $240.00 | < 1% 38.83M to 38.84M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 20-Oct-17 | Purchase | 10,000 | $0.02 | $200.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 18-Oct-17 | Purchase | 30,000 | $0.02 | $702.00 | < 1% 38.81M to 38.84M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 16-Oct-17 | Purchase | 2,000 | $0.03 | $60.00 | < 1% 22.06M to 22.06M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 13-Oct-17 | Purchase | 27,000 | $0.03 | $760.00 | < 1% 22.03M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 13-Oct-17 | Purchase | 50,000 | $0.03 | $1,322.00 | < 1% 38.79M to 38.84M | |
| 29-Mar-18 10:00 PM View: | Dailey Robert Jackman | Immune Therapeutics, Inc. (IMUN) | 12-Oct-17 | Purchase | 10,000 | $0.02 | $200.00 | < 1% 22.05M to 22.06M | |
| 02-Apr-18 10:00 PM View: | Gostanian Richard | Immune Therapeutics, Inc. (IMUN) | 11-Oct-17 | Purchase | 30,000 | $0.02 | $690.00 | < 1% 38.81M to 38.84M |
